Vitamin D deficiency increases the risk of oral lichen planus: Study

A new study published in the International Journal of Women’s Health showed that a lack of vitamin D may make oral lichen planus (OLP) more likely. Given their potential to hasten the healing process, vitamin D delivery and assessment were crucial factors in therapy choices for OLP patients.

The chronic inflammatory mucocutaneous disease known as oral lichen planus is typified by immune-mediated destruction to the oral epithelium and painful erosive lesions. A major management problem arises from recalcitrant instances of OLP, which do not react well to standard treatments like corticosteroids and immunosuppressants.

Recent research has demonstrated that vitamin D’s immunomodulatory, anti-inflammatory, and epithelial-healing qualities may make it useful as an adjuvant therapy. Three key processes in the pathophysiology of OLP are influenced by vitamin D: cytokine balance, keratinocyte development, and T-cell modulation.

Increased disease activity and delayed healing in mucosal illnesses have been associated with vitamin D deficiency. Therefore, in situations of resistant OLP, supplementation may relieve clinical symptoms, lessen the severity of lesions, and improve quality of life. Examining vitamin D’s therapeutic potential provides encouraging information on a more secure, economical, and environmentally friendly method of treating resistant oral lichen planus. This case study examined stubborn OLP that persisted for more than a year and shown how important vitamin D is for promoting wound healing.

This case study was 1 and 3 years ago, 2 female patients, ages 50 and 58, complained of pain in their left and right cheeks. Despite receiving prior treatments, neither patient had exhibited any improvement. On the left and right buccal mucosa, an intraoral examination showed erosive lesions with Wickham striae. Research identified reticular and erosive OLP in both individuals.

Anti-inflammatory medication and mouthwash containing corticosteroids were the initial treatments for both individuals. Because of the severity and persistence of the clinical symptoms, a screening for risk factors was conducted, including an assessment of vitamin D 25 (OH) levels.

Both patients got vitamin D replacement treatment after the evaluation revealed a vitamin D deficit. The final control demonstrated that there were notable improvements in the patients’ subjective and objective complaints.

Overall, a lack of vitamin D raised the risk of OLP. Vitamin D delivery and evaluation were crucial factors in therapy choices for OLP patients as they may hasten the healing process.

Source:

Rahmadhini, E. N., Hidayat, W., & Zakiawati, D. (2025). Vitamin D in the treatment of recalcitrant oral lichen planus: A case series. International Journal of Women’s Health, 17, 3229–3239. https://doi.org/10.2147/IJWH.S527877

Powered by WPeMatico

Open-label placebo Improves Quality of Life but Not Headache Frequency in Migraine: JAMA

A new study published in the Journal of the American Medical Association revealed that open-label placebo (OLPs) treatment did not reduce migraine frequency but enhanced quality of life and reduced pain-related disability, warranting further investigation. The trial explored whether taking placebos knowingly could offer benefits to migraine sufferers without the ethical dilemma of deception. Placebo effects have long been known to play a major role in the success of various treatments, particularly those targeting pain.

From November 2020 to November 2022, this research enrolled 120 adult patients diagnosed with episodic or chronic migraine. The median age was just over 34 years, and the vast majority (86%) were women, who were consistent with known migraine demographics. The participants were randomly assigned to receive either open-label placebo pills in addition to their usual treatment (OLP + TAU) or their usual treatment alone (TAU).

The OLP group was instructed to take the pills twice daily for 3 months, fully informed that the capsules contained no active medication but had been shown in prior research to trigger beneficial mind–body responses.

This research compared changes in headache frequency and found no statistically significant difference between those taking OLPs and those relying solely on standard care. Both groups experienced roughly similar numbers of headache and migraine days by the end of the 3-month period.

However, secondary outcomes revealed a more encouraging picture. The participants who took OLPs reported marked improvements in daily functioning and overall well-being. Scores on the 12-Item Short-Form Health Survey showed a meaningful rise in the physical quality-of-life index (average increase of 4.25 points, P = .01).

Measures of pain-related disability also improved, where the Pain Disability Index dropped by nearly 6 points on average, and the Headache Impact Test showed a modest but statistically significant improvement. Moreover, patients in the OLP group rated their overall condition as “globally improved” far more often than those receiving usual care.

Although the placebo pills did not reduce headache frequency or intensity, these findings suggest that their positive influence on patients’ perceived well-being and functional ability warrants further study. Future studies are expected to investigate how open-label placebos activate brain mechanisms related to pain perception and self-healing. 

Source:

Kleine-Borgmann, J., Schmidt, K., Ludwig, L., Schulz, M., Holle-Lee, D., Gaul, C., & Bingel, U. (2025). Open-label placebos as adjunct for the preventive treatment of migraine: A randomized clinical trial: A randomized clinical trial. JAMA Network Open, 8(10), e2535739. https://doi.org/10.1001/jamanetworkopen.2025.35739

Powered by WPeMatico

Hormone replacement therapy may help restore immunity in menopausal women: Study

A study led by researchers at Queen Mary University of London has found that hormone replacement therapy (HRT) may help reverse changes in the immune system caused by menopause, potentially booting immune health. The research reveals new evidence that menopause significantly alters women’s immune system, increasing their vulnerability to infections.

The study, published in Aging Cell is the first detailed analysis of how ageing and sex differences influence monocytes, a key group of immune cells that act as the body’s first responders to infection. Analysing blood samples from younger adults less than 40 years of age and older adults aged 65 and above, the team found that after menopause, women develop more inflammatory types of white blood cells called monocytes, which are less effective at clearing bacteria.

These changes were linked to lower levels of complement C3, an immune protein that helps monocytes engulf and destroy harmful microbes. In contrast, men of the same age did not show these changes, suggesting menopause has a uniquely disruptive effect on female immunity.

To test whether hormone therapy could influence this decline, the researchers studied peri-and post-menopausal women taking HRT. They found that these women had healthier immune profiles, with fewer inflammatory monocytes and stronger infection-fighting ability as compared to age-matched controls. Levels of complement C3 in their blood were also higher in those taking HRT, bringing them close to the immune status of younger women.

Dr Emma Chambers, Senior Lecturer in Immunology at Queen Mary and lead author of the study said: “Our findings highlight menopause as a critical turning point for women’s immunity. While ageing affects everyone, the loss of female hormones appears to accelerate immune decline in women. Encouragingly, hormone therapy seems to restore key aspects of immune health, offering benefits that go beyond easing menopausal symptoms.”

Fiona Miller Smith, Chief Executive of Barts Charity, said: “We’re proud to have supported this pioneering research. This is a brilliant example of how funding innovative ideas in health can lead to advances in our understanding – this time around menopause and women’s immune systems. These findings could have a huge impact for women in our East London community and beyond.”

Menopause typically occurs in women between the ages of 45 and 55 and is often preceded by a decade-long peri-menopausal phase. Symptoms such as hot flushes, joint pain, fatigue and brain fog can have a profound effect on quality of life. In the UK alone, more than four million women are in this age bracket, and women over 50 make up a growing proportion of the workforce. Yet they are also among the most likely to experience work disruption due to menopausal symptoms.

HRT is already prescribed to manage symptoms, but this study suggests it may also help maintain immune health and reduce infection risk in later life. The researchers caution, however, that more work is needed to confirm whether HRT reduces real-world infection rates, and to understand how different formulations or delivery methods affect the immune system.

The authors caution that while the findings are promising, the study does not mean HRT should automatically be prescribed for immune health. More research is needed to confirm whether women taking HRT have lower infection rates in real-world settings, and to investigate how different types and route of HRT administration may affect the immune system. 

Reference:

R. P. H. De Maeyer, J. Sikora, O. V. Bracken, B. Shih, A. F. Lloyd, H. Peckham, K. Hollett, K. Abdelhamid, W. Cai, M. James, P. E. Pfeffer, M. Vukmanovic-Stejic, A. N. Akbar, E. S. Chambers, Age-Associated Inflammatory Monocytes Are Increased in Menopausal Females and Reversed by Hormone Replacement Therapy, Aging Cell, https://doi.org/10.1111/acel.70249

Powered by WPeMatico

ESIC Medical College Indore gets NMC approval to begin MBBS course with 50 seats

Indore: The Employees’ State Insurance Corporation (ESIC) Medical College, Indore, has received permission from the National Medical Commission (NMC) to start the MBBS course with 50 seats from the academic session 2025-26.

On Friday, ESIC Medical College, Indore, announced that it has received the coveted Letter of Permission (LOP) from the NMC to start the MBBS course with 50 seats from the academic session 2025-26. This decision by the NMC comes after the institute completed extensive infrastructural and academic preparations to meet world-class standards.

According to Pulkit Jain, Deputy Director, ESIC Indore, the college administration attributed this success to the “relentless hard work, excellent coordination, and dedication” of the entire institutional team over the past seven to eight months. Mr Jain added, “The permission of the MBBS course will usher in a new era of access to high-quality medical education and healthcare in Indore, directly benefiting students, insured persons, and the general public.”

He further said that the credit for this historic achievement especially goes to Dean Dr Rajesh U Sangram, while the collaborative efforts of Joint Director Dr Mo Rubani and all the departmental and staff members were also instrumental in achieving this goal.

According to a Times of India report, the 65-acre campus includes a six-story hospital with 420 beds, including 20 emergency beds. The hospital building’s first and third floors house the outpatient department (OPDs), while the upper floors house classrooms and administrative sections. Faculty and staff recruitment has been completed, with a total strength of approximately 102.

Moreover, the college has established new, separate hostels for boys and girls, and residential quarters for teachers. It features smart classrooms equipped with modern technology, a fully functional digital library, and all necessary teaching aids. All laboratory facilities, including workstations, medical equipment, and cadaver storage rooms, are ready according to NMC standards. Blood bank services are currently operational through a Memorandum of Understanding and will soon be converted to an in-house facility.

Powered by WPeMatico

Haryana doctors oppose Govt order to conduct food sampling

Chandigarh: Raising strong objections to the state government’s decision to assign medical officers the responsibility of collecting food samples and checking adulteration under the Food Safety and Standards Act, the Haryana Civil Medical Services (HCMS) Association has refused to accept this decision, stating that doctors are neither trained nor equipped to perform such legally sensitive tasks. 

In a letter submitted by the association on October 7, food sampling requires specific procedures and training, as even a small mistake could lead to legal trouble for the officers and the department involved.  

Also read- Haryana doctors launch hunger strike against Geo-fencing Attendance System

“The food sampling involved technical sampling procedures, documentation, and compliance with intricate legal protocols. The food sampling process has significant legal implications, and any procedural lapse, even inadvertent, could lead to complications, including the possibility of litigation. The absence of formal training and standardised operating procedures exposes both the concerned officers and the department to unnecessary risks,” stated the letter. 

As per HT media report, the opposition comes after the Food and Drugs Administration directed civil surgeons on October 3 to direct deputy civil surgeons, senior medical officers in-charge of sub divisional hospitals and community health centres and medical officers in-charge of primary health centres who had been notified as food safety officers to take food samples particularly milk products during the festival season due to shortage of food safety officers.

In this regard, HCMS general secretary, Dr Anil Yadav, said, “Under the current arrangement, medical officers are expected to seek directions from designated class II officers who are junior in official hierarchy to the doctors. This not only creates an administrative anomaly but is also contrary to established government protocol. Such an arrangement undermined the professional standing of medical officers and may lead to practical difficulties and confusion in coordination, accountability, and chain of command. Furthermore, food adulteration is a highly sensitive public health issue which demands a specialised, robust and dedicated mechanism for effective food safety enforcement rather than resorting to temporary or makeshift arrangements.”

Also read- Haryana Doctors Association writes to CM over vacant posts, promotion delays

Powered by WPeMatico

Ketogenic diet may protect against stress experienced in the womb

Researchers have shown that young rats fed a ketogenic diet—a diet with high fat and low carbohydrates—are protected from the lasting experience of pre‑natal stress. This work, which has not yet been confirmed in humans, was presented at the ECNP conference in Amsterdam.

Powered by WPeMatico

Should we decide by lottery who gets a medical treatment first?

For decades, ethicists have argued that lotteries could be the fairest way to decide who gets life-saving treatment when there isn’t enough to go around. Yet our research suggests that most people would rather leave the choice to medical experts than to luck.

Powered by WPeMatico

Child famine has reached the highest level in Gaza, with tens of thousands of kids affected—new study

More than 54,000 children aged under five in Gaza are suffering acute malnutrition, including more than 12,800 who are severely malnourished, according to a study published in The Lancet on Wednesday.

Powered by WPeMatico

Adults 65 years and older not immune to the opioid epidemic, study finds

Overdose deaths in adults age 65 and older from fentanyl mixed with stimulants, such as cocaine and methamphetamines, have surged 9,000% in the past eight years, matching rates found among younger adults, according to research presented at the ANESTHESIOLOGY 2025 annual meeting.

Powered by WPeMatico

Kerala CM urges Centre to approve AIIMS at Kozhikode

Thiruvananthapuram: Kerala Chief Minister Pinarayi Vijayan on Friday urged Prime Minister Narendra Modi to expedite the approval for establishing an All India Institute of Medical Sciences (AIIMSat Kinaloor in Kozhikode district, which is the site already earmarked by the state government.

Speaking to reporters in Delhi, Vijayan confirmed that he had also made a request to Union Health Minister JP Nadda to expedite the final approval for setting up the premier medical institute. Kerala has been demanding an AIIMS for a decade.

According to a PTI report, the CM’s request to Modi and Nadda comes amidst Union Minister of State Suresh Gopi’s recent call for setting up an All India Institute of Medical Sciences (AIIMS) at Alappuzha.

Also Read:AIIMS for Kerala will be announced at the right time, place: JP Nadda

Gopi, the Union Minister of State for Petroleum, Natural Gas and Tourism, had recently said that he has identified a place in the coastal Alappuzha district for setting up an AIIMS, and if it’s not established there, he has a right to ask where it should come up.

When reporters pointed this out to the CM, he said it was better not to respond to such statements.

“We (Kerala) have only asked for setting up AIIMS at Kozhikode. That is the only site before us. So, that is where it has to be set up.

In addition to the AIIMS demand, the CM informed both the PM and the Health Minister that the state has sought permission for setting up an ICMR-National Institute for Geriatric Care and Healthy Ageing.

“We have already acquired land for it as per the central government’s instructions and if anything additional is required, we are ready to provide that as well,” the CM said.

He said that his request to Nadda, also contained details of the efforts made by the state to get the AIIMS sanctioned.

Vijayan said that Kerala has been demanding an AIIMS for a decade, and urged Nadda to take steps for the necessary clearances from the Finance Ministry.

While Vijayan met Union Finance Minister Nirmala Sitharaman on Thursday, he did not raise the AIIMS issue with her.

He said that the state has asked that the AIIMS project be included in the next phase of the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY), issue official orders allocating the premier medical institute to Kerala and send a team to study whether the identified land was feasible for it, reports PTI.

Vijayan said that he explained to the PM and Nadda the importance of the matter and received a good response from them.

He said that the state has sought permission for setting up the National Institute for Geriatric Care and Healthy Ageing in view of its unique demographic structure and its increasing elderly population.

The objective is to make the institute India’s best centre for research, innovation, policy and service delivery in geriatric care and healthy ageing, for improving the health, dignity and quality of life of senior citizens, the Marxist veteran said.

“It will help address the urgent needs of the ageing population in the state and serve as a model for other countries going through similar demographic changes as India,” Vijayan said.

He contended that both the AIIMS and the National Institute for Geriatric Care and Healthy Ageing will complement each other.

“It is expected that the Centre will fulfil the assurances given to the state government,” the CM said.

Also Read:Kerala HC Seeks Clarification on AIIMS Site Selection in Kozhikode

Powered by WPeMatico